GUTS
Price
$1.51
Change
+$0.01 (+0.67%)
Updated
May 7, 04:59 PM (EDT)
Capitalization
73.46M
12 days until earnings call
INZY
Price
$1.33
Change
+$0.07 (+5.56%)
Updated
May 7, 04:59 PM (EDT)
Capitalization
95.72M
6 days until earnings call
Ad is loading...

GUTS vs INZY

Header iconGUTS vs INZY Comparison
Open Charts GUTS vs INZYBanner chart's image
Fractyl Health
Price$1.51
Change+$0.01 (+0.67%)
Volume$851
Capitalization73.46M
Inozyme Pharma
Price$1.33
Change+$0.07 (+5.56%)
Volume$4.91K
Capitalization95.72M
GUTS vs INZY Comparison Chart
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. INZY commentary
May 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a StrongBuy and INZY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 08, 2025
Stock price -- (GUTS: $1.50 vs. INZY: $1.26)
Brand notoriety: GUTS and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 86% vs. INZY: 239%
Market capitalization -- GUTS: $73.46M vs. INZY: $95.72M
GUTS [@Biotechnology] is valued at $73.46M. INZY’s [@Biotechnology] market capitalization is $95.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, INZY is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 5 TA indicator(s) are bullish while INZY’s TA Score has 5 bullish TA indicator(s).

  • GUTS’s TA Score: 5 bullish, 5 bearish.
  • INZY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than GUTS.

Price Growth

GUTS (@Biotechnology) experienced а +19.05% price change this week, while INZY (@Biotechnology) price change was +18.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.53%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was -14.13%.

Reported Earning Dates

GUTS is expected to report earnings on May 19, 2025.

INZY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-4.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($95.7M) has a higher market cap than GUTS($73.5M). GUTS YTD gains are higher at: -27.184 vs. INZY (-54.513). GUTS (-92.85M) and INZY (-95.72M) have comparable annual earnings (EBITDA) . INZY has more cash in the bank: 113M vs. GUTS (67.5M). INZY has less debt than GUTS: INZY (46.9M) vs GUTS (62.5M). GUTS has higher revenues than INZY: GUTS (93K) vs INZY (0).
GUTSINZYGUTS / INZY
Capitalization73.5M95.7M77%
EBITDA-92.85M-95.72M97%
Gain YTD-27.184-54.51350%
P/E RatioN/AN/A-
Revenue93K0-
Total Cash67.5M113M60%
Total Debt62.5M46.9M133%
TECHNICAL ANALYSIS
Technical Analysis
GUTSINZY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGRFX82.80N/A
N/A
Baron Growth Retail
RYICX97.80N/A
N/A
Rydex Internet C
TVLCX11.30N/A
N/A
Touchstone Value C
JOSSX49.12N/A
N/A
Johnson Opportunity S
RTSCX28.73-0.28
-0.97%
Russell Inv Tax-Managed US Mid&Sm Cap C

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with INZY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-7.98%
INZY - GUTS
34%
Loosely correlated
-15.44%
CABA - GUTS
34%
Loosely correlated
-10.16%
PRME - GUTS
34%
Loosely correlated
-15.29%
KYTX - GUTS
34%
Loosely correlated
-5.63%
IPSC - GUTS
34%
Loosely correlated
-5.54%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-15.44%
IGMS - INZY
51%
Loosely correlated
-9.30%
ERAS - INZY
51%
Loosely correlated
-13.79%
BEAM - INZY
49%
Loosely correlated
-19.32%
APGE - INZY
48%
Loosely correlated
-9.70%
IDYA - INZY
48%
Loosely correlated
-13.29%
More